Pharmala Biotech Holdings Inc. (CSE:MDMA)
Canada · Delayed Price · Currency is CAD 0.1150
+0.0050 (4.55%)
Sep 8, 2025, 9:58 AM EDT
Pharmala Biotech Holdings Market Cap
Pharmala Biotech Holdings has a market cap or net worth of CAD 11.73 million as of September 8, 2025. Its market cap has increased by 21.76% in one year.
Market Cap
11.73M
Enterprise Value
10.48M
Revenue
420.81K
Ranking
n/a
PE Ratio
n/a
Stock Price
0.12
Market Cap Chart
Since January 11, 2022, Pharmala Biotech Holdings's market cap has increased from 6.64M to 11.73M, an increase of 76.61%. That is a compound annual growth rate of 16.85%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Sep 5, 2025 | 11.73M | -54.61% |
| Dec 31, 2024 | 25.84M | 112.35% |
| Dec 29, 2023 | 12.17M | 486.37% |
| Dec 30, 2022 | 2.07M | -68.75% |
| Jan 11, 2022 | 6.64M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Curaleaf Holdings | 2.96B |
| Green Thumb Industries | 2.54B |
| Trulieve Cannabis | 1.91B |
| Sienna Senior Living | 1.64B |
| dentalcorp Holdings | 1.62B |
| Cronos Group | 1.32B |
| WELL Health Technologies | 1.19B |
| Extendicare | 1.09B |